Heat tolerance is not merely a matter of fitness — it depends on intact neurochemical signaling pathways that govern sweating and skin blood flow. For the roughly 280 million people worldwide living with major depressive disorder, impaired thermoregulation during heat stress may represent an underappreciated physiological vulnerability, particularly as climate-driven extreme heat events intensify globally.
This controlled study enrolled 64 women aged 18–36, divided equally across four groups: unmedicated MDD, SSRI-treated MDD, SNRI-treated MDD, and non-depressed controls. Participants were passively heated using a water-perfused suit until core temperature rose 1.0°C. Forearm vascular conductance (FVC) — a measure of cutaneous vasodilation critical for heat dissipation — was significantly lower in unmedicated MDD women compared to non-depressed controls and SSRI-treated participants. SSRI treatment appeared to normalize this vascular response, whereas SNRI-treated women showed intermediate FVC values that were statistically indistinguishable from either unmedicated MDD or non-depressed controls, but significantly lower than the SSRI group. Local sweat rate data and skin blood flow via laser-Doppler flowmetry were also continuously recorded, suggesting the deficit spans multiple thermoregulatory effector mechanisms.
The findings slot into an emerging picture of MDD as a disorder with measurable peripheral autonomic consequences, not just central mood dysregulation. Prior work has noted altered circadian core temperature rhythms in depression, but this study is among the first to experimentally quantify heat-stress thermoregulatory capacity across medication status in the same cohort design. The SSRI-versus-SNRI divergence is particularly intriguing: both drug classes inhibit serotonin reuptake, but SNRIs' additional norepinephrine action may differentially modulate cutaneous vascular tone in ways that partially counteract therapeutic benefit. Key limitations include the exclusively female, young-adult sample — generalizability to men, older adults, or those with comorbidities remains untested — and the cross-sectional design, which cannot establish whether MDD causes thermoregulatory blunting or whether a shared neurochemical substrate underlies both. This is an incremental but carefully designed contribution that raises clinically meaningful questions about heat safety in people with depression.